This inventor holds 1 USPTO granted patent. Top assignee: Storm Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tommaso Canelli: Innovator in Inhibitory Compounds
Introduction
Tommaso Canelli is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit specific biological activities. His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Canelli holds a patent for "Processes for the preparation of inhibitory compounds." This invention relates to processes for the preparation of certain compounds that function as inhibitors of METTL3 (N6-adenosine-methyltransferase 70 kDa subunit) activity, along with their synthetic intermediates. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Currently, Tommaso Canelli is associated with Storm Therapeutics Limited, a company focused on developing therapies that target RNA-modifying enzymes. His role at the company allows him to apply his expertise in creating novel compounds that can potentially lead to groundbreaking treatments.
Collaborations
Canelli collaborates with various professionals in his field, including his coworker Christian Bubert. Their combined efforts contribute to the advancement of research and development in therapeutic innovations.
Conclusion
Tommaso Canelli is a prominent figure in the field of medicinal chemistry, with a focus on inhibitory compounds. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile